186 related articles for article (PubMed ID: 14586396)
1. Considering therapeutic options in the real world.
Martin RJ
J Allergy Clin Immunol; 2003 Nov; 112(5 Suppl):S112-5. PubMed ID: 14586396
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma'].
Diamant Z; Dekhuijzen PN
Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1681-5. PubMed ID: 14513539
[TBL] [Abstract][Full Text] [Related]
3. Costs and resource use of mild persistent asthma patients initiated on controller therapy.
Colice GL; Yu AP; Ivanova JI; Hsieh M; Birnbaum HG; Lage MJ; Brewster C
J Asthma; 2008 May; 45(4):293-9. PubMed ID: 18446593
[TBL] [Abstract][Full Text] [Related]
4. Leukotriene antagonists as first-line or add-on asthma-controller therapy.
Price D; Musgrave SD; Shepstone L; Hillyer EV; Sims EJ; Gilbert RF; Juniper EF; Ayres JG; Kemp L; Blyth A; Wilson EC; Wolfe S; Freeman D; Mugford HM; Murdoch J; Harvey I
N Engl J Med; 2011 May; 364(18):1695-707. PubMed ID: 21542741
[TBL] [Abstract][Full Text] [Related]
5. Comparative outcomes of leukotriene receptor antagonists and long-acting β-agonists as add-on therapy in asthmatic patients: a population-based study.
Sadatsafavi M; Lynd L; Marra C; Bedouch P; Fitzgerald M
J Allergy Clin Immunol; 2013 Jul; 132(1):63-9. PubMed ID: 23545274
[TBL] [Abstract][Full Text] [Related]
6. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
[TBL] [Abstract][Full Text] [Related]
7. Adherence to anti-inflammatory treatment for asthma in clinical practice in France.
Latry P; Pinet M; Labat A; Magand JP; Peter C; Robinson P; Martin-Latry K; Molimard M
Clin Ther; 2008; 30 Spec No():1058-68. PubMed ID: 18640480
[TBL] [Abstract][Full Text] [Related]
8. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
[TBL] [Abstract][Full Text] [Related]
9. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K
Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study.
Niven R; Chung KF; Panahloo Z; Blogg M; Ayre G
Respir Med; 2008 Oct; 102(10):1371-8. PubMed ID: 18657960
[TBL] [Abstract][Full Text] [Related]
11. Complementary therapy in asthma: inhaled corticosteroids and what?
Bjermer L; Diamant Z
Curr Opin Pulm Med; 2009 Jan; 15(1):46-51. PubMed ID: 19077705
[TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness of asthma controller therapies: influence of disease severity and other variables.
Navarro RP; Parasuraman B
Manag Care Interface; 2005 Jun; 18(6):31-40. PubMed ID: 16018297
[TBL] [Abstract][Full Text] [Related]
13. Drug therapy of childhood asthma.
Balachandran A; Shivbalan S; Subramanyam L
Indian J Pediatr; 2001 Sep; 68 Suppl 4():S12-6. PubMed ID: 11980463
[TBL] [Abstract][Full Text] [Related]
14. Treating asthma: is there a place for leukotriene receptor antagonists?
Diamant Z; van der Molen T
Respir Med; 2005 Jun; 99(6):655-62. PubMed ID: 15878481
[TBL] [Abstract][Full Text] [Related]
15. Addition of leukotriene receptor antagonists to inhaled corticosteroids improved QOL of patients with bronchial asthma surveyed in suburban Tokyo, Japan.
Ohshima N; Matsui H; Matsui Y; Kawashima M; Shimada M; Higaki N; Shoji S; Wada H; Fujita A; Watanabe H; Yamaguchi N; Matsuoka R; Oki K; Takahashi H; Suzuki M; Yamazaki H; Yoshizawa M; Goto H
Allergol Int; 2011 Dec; 60(4):473-81. PubMed ID: 21681017
[TBL] [Abstract][Full Text] [Related]
16. Evaluating combination therapies for asthma: pros, cons, and comparative benefits.
Bjermer L
Ther Adv Respir Dis; 2008 Jun; 2(3):149-61. PubMed ID: 19124367
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations.
Gibson PG; Powell H; Ducharme FM
J Allergy Clin Immunol; 2007 Feb; 119(2):344-50. PubMed ID: 17291852
[TBL] [Abstract][Full Text] [Related]
18. Use of leukotriene receptor antagonists are associated with a similar risk of asthma exacerbations as inhaled corticosteroids.
Wu AC; Li L; Fung V; Kharbanda EO; Larkin EK; Vollmer WM; Butler MG; Miroshnik I; Rusinak D; Davis RL; Hartert T; Weiss ST; Lieu TA
J Allergy Clin Immunol Pract; 2014; 2(5):607-13. PubMed ID: 25213056
[TBL] [Abstract][Full Text] [Related]
19. The management of asthma and rhinitis during pregnancy.
Osur SL
J Womens Health (Larchmt); 2005 Apr; 14(3):263-76. PubMed ID: 15857273
[TBL] [Abstract][Full Text] [Related]
20. Current treatment options for asthma in adults.
Canham EM; Martin RJ
Panminerva Med; 2005 Jun; 47(2):109-22. PubMed ID: 16210996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
